Inhibrx Biosciences, Inc.
Multivalent and Multispecific DR5-Binding Fusion Proteins

Last updated:

Abstract:

The disclosure relates generally to molecules that specifically engage death receptor 5 (DR5), a member of the TNF receptor superfamily (TNFRSF). More specifically the disclosure relates to multivalent and multispecific molecules that bind at least DR5.

Status:
Application
Type:

Utility

Filling date:

5 Aug 2021

Issue date:

3 Mar 2022